# CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CRL/mda/fy2025/): filed 2026-02-18; accession 0001100682-26-000022 (https://www.sec.gov/Archives/edgar/data/1100682/000110068226000022/crl-20251227.htm); latest 10-K
- [FY 2024 MD&A](/company/CRL/mda/fy2024/): filed 2025-02-19; accession 0001100682-25-000011 (https://www.sec.gov/Archives/edgar/data/1100682/000110068225000011/crl-20241228.htm)
- [FY 2023 MD&A](/company/CRL/mda/fy2023/): filed 2024-02-14; accession 0001100682-24-000007 (https://www.sec.gov/Archives/edgar/data/1100682/000110068224000007/crl-20231230.htm)
- [FY 2022 MD&A](/company/CRL/mda/fy2022/): filed 2023-02-22; accession 0001100682-23-000006 (https://www.sec.gov/Archives/edgar/data/1100682/000110068223000006/crl-20221231.htm)
- [FY 2021 MD&A](/company/CRL/mda/fy2021/): filed 2022-02-16; accession 0001100682-22-000007 (https://www.sec.gov/Archives/edgar/data/1100682/000110068222000007/crl-20211225.htm)

Back to /company/CRL/